Through CancerLinQ Discovery®, CancerLinQ provides the oncology research community access to de-identified datasets representing more than 6 million patient records to generate practical knowledge to shape the future of cancer care. Academic, government, non-profit, and industry researchers can use CancerLinQ Discovery datasets to un-lock new insights that can improve patient care and generate new research hypotheses –with the vision of learning from the experience of every cancer patient.
CancerLinQ Discovery Data
CancerLinQ Discovery contains data from CancerLinQ’s diverse network of community, academic, and health system care settings, and other data sources such as oncology care pathway tools and registry files. To date, CancerLinQ Discovery data has been used in dozens of publications in addition to efforts focused on advancing clinical development programs.
health record systems
Available Data Sets
CancerLinQ is proud to offer CancerLinQ Discovery data sets across the following 10 tumor types.
A Community That Learns Together
CancerLinQ Discovery is building a community that learns together and shares insights to improve patient care and outcomes. In 2016, Founding Enterprise Partner AstraZeneca became the first industry strategic partner to join in the mission of CancerLinQ Discovery. Since then, CancerLinQ has established collaborations with government agencies, including the U.S. Food and Drug Administration, medical specialty societies, and other health technology companies. Interested in joining their collaborative community of learning? Email email@example.com